Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.21.2
SHARE-BASED COMPENSATION
9 Months Ended
Sep. 30, 2021
SHARE-BASED COMPENSATION  
SHARE-BASED COMPENSATION

NOTE 9 – SHARE-BASED COMPENSATION

Stock Options

The Company has a Global Stock Incentive Plan (the “Plan”) under which the Company may grant stock options for up to 1,503,421 common shares. Both incentive stock options and non-qualified stock options expire ten years from the date of the grant.

NOTE 9 – SHARE-BASED COMPENSATION (CONTINUED)

The following table summarizes the stock option activity:

Weighted Average 

Aggregate 

Number of 

Weighted Average 

Remaining 

Intrinsic 

    

Options

    

Exercise Price

    

Contractual Term

    

Value

Balance at January 1, 2021

 

468,070

$

0.14

 

9.25

$

1,315,512

Granted

 

1,016,722

 

2.41

 

  

 

  

Forfeited/Cancelled

 

(64,042)

 

0.002

 

  

 

  

Exercised

 

(22,524)

 

0.002

 

  

 

  

Balance at September 30, 2021

 

1,398,226

 

1.80

 

9.22

$

1,095,303

Exercisable at September 30, 2021

 

332,391

$

1.27

 

8.92

$

436,739

    

Weighted Average 

Aggregate 

Number of 

Weighted Average 

Remaining 

Intrinsic 

    

Options

    

Exercise Price

    

Contractual Term

    

Value

Balance at January 1, 2020

 

$

 

 

Granted

 

468,070

 

0.14

 

  

 

  

Forfeited/Cancelled

 

 

 

  

 

  

Exercised

 

 

 

  

 

  

Balance at September 30, 2020

 

468,070

 

0.14

 

9.50

$

932,288

Exercisable at September 30, 2020

 

33,294

$

0.002

 

9.50

$

70,886

The following table summarizes the Company’s non-vested stock options:

Weighted-Average 

Non-vested Options 

Grant Date Fair

    

Outstanding

    

 Value

At January 1, 2021

427,035

$

1.21

Options granted

 

1,016,722

 

0.99

Options forfeited/cancelled

 

(64,042)

 

1.88

Options exercised

 

(22,524)

 

1.41

Options vested

 

(291,356)

 

0.97

At September 30, 2021

 

1,065,835

$

0.93

Weighted-Average 

Non-vested Options 

Grant Date Fair

    

Outstanding

    

Value

At January 1, 2020

 

$

Options granted

 

468,070

 

1.22

Options forfeited/cancelled

 

 

Options exercised

 

 

Options vested

 

(33,294)

 

1.41

At September 30, 2020

 

434,776

$

1.21

NOTE 9 – SHARE-BASED COMPENSATION (CONTINUED)

For the three and nine months ended September 30, 2021, the Company recognized $111,552 and $270,247 of stock compensation expense relating to stock options, respectively. For the three and nine months ended September 30, 2020, the Company recognized $35,908 and $113,576 of stock compensation expense relating to stock options, respectively. As of September 30, 2021, there was $1,135,350 of unrecognized stock compensation expense related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of four years.

Restricted Stock Awards

In July 2019, the Board of Directors authorized grants of restricted stock awards (“RSAs”) through a restricted stock award purchase agreement to certain founders, consultants, and advisors of the Company. Certain grants to the Company’s founders were fully vested at the date of incorporation, other grants vest over a four-year period on each anniversary of the grant date, based on continued employment, and other grants vested based on various milestones. The shares of common stock underlying the RSAs are issued upon grant.

The following table summarizes the restricted stock awards activity:

Weighted-Average 

Restricted Stock 

Grant Date Fair Value 

    

Awards

    

Per Share

Outstanding at January 1, 2021

 

1,618,565

$

1.47

Granted

 

 

Forfeited/cancelled

 

(107,271)

 

1.80

Vested

 

(692,072)

 

1.43

Outstanding at September 30, 2021

 

819,222

$

1.42

Outstanding at January 1, 2020

 

2,130,689

$

1.41

Granted

 

134,397

 

2.13

Forfeited/cancelled

 

 

Vested

 

(516,398)

 

1.41

Outstanding at September 30, 2020

 

1,748,688

$

1.41

For the three and nine months ended September 30, 2021, the Company recognized $144,585 and $691,896 of stock compensation expense relating to RSAs, respectively. For the three and nine months ended September 30, 2020, the Company recognized $158,739 and $722,580 of stock compensation expense relating to RSAs, respectively. As of September 30, 2021, there was $1,090,842 of unrecognized compensation expense related to unvested restricted share awards that is expected to be recognized over a weighted-average period of 2 years.